Literature DB >> 8112353

Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium.

R Janknegt1, W J Wijnands, M Caprasse, W Brandenburg, M G Schuitenmaker, E Stobberingh.   

Abstract

Data on the use of antimicrobial drugs was collected by means of an inquiry to 30 hospitals in Belgium (15 in Dutch sectors and 15 in the French sectors), 21 hospitals in Germany and 20 hospitals in the Netherlands. The use of these drugs was expressed as the number of defined daily doses (DDD) per 100 bed days by the anatomical therapeutical chemical classification system. The total use of antimicrobial agents was significantly (p < 0.001) higher in both parts of Belgium (55.6 and 52.0 DDD per 100 bed days) than in Germany (37.9 DDD) or the Netherlands (34.1 DDD). In particular, amoxicillin-clavulanic acid, the first- and second-generation cephalosporins, aminoglycosides and fluoroquinolones were used more in Belgium than in either of the other countries. At least part of the differences observed in antimicrobial drug use could be explained by differences in written antibiotic policy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112353     DOI: 10.1007/bf02000403

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

Review 1.  Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance.

Authors:  H C Neu; R J Duma; R N Jones; J E McGowan; T F O'Brien; L D Sabath; C C Sanders; W Schaffner; F C Tenover; L S Young
Journal:  Diagn Microbiol Infect Dis       Date:  1992-02       Impact factor: 2.803

2.  Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study.

Authors:  L Verbist
Journal:  Scand J Infect Dis Suppl       Date:  1991

3.  Statistics at square one. XII--The t tests (continued).

Authors:  T D Swinscow
Journal:  Br Med J       Date:  1976-08-07

4.  XI--The t tests.

Authors:  T D Swinscow
Journal:  Br Med J       Date:  1976-07-31

5.  Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.

Authors:  M Y Ma; E J Goldstein; M H Friedman; M S Anderson; M E Mulligan
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

6.  Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study.

Authors:  R J Buirma; A M Horrevorts; J H Wagenvoort
Journal:  Scand J Infect Dis Suppl       Date:  1991

7.  Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

Authors: 
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

  7 in total
  6 in total

1.  The system of objective judgement analysis method: less objectivity than pretended?

Authors:  P Schacht; D Bosse; R Kubin
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 2.  The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1997-06

3.  Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine.

Authors:  I C Gyssens; W L Blok; P J van den Broek; Y A Hekster; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

4.  Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experience.

Authors:  M C Closon; R Crott; D Even-Adin
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 5.  Antimicrobial drug utilisation in hospitals in Italy and other European countries.

Authors:  L Guglielmo; R Leone; U Moretti; A Conforti; G P Velo
Journal:  Infection       Date:  1994       Impact factor: 3.553

6.  Multiply resistant pneumococci in The Netherlands.

Authors:  Y Holloway; J Schiphuis; M Kooistra-Smid; J A Snijder; P C Appelbaum; S K Spangler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.